Trial Profile
Effectiveness of Atorvastatin on IL2, IL6, TNFalpha and HLA Levels in the Recipient's Kidney Graft From a Living Donor
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Kidney disorders
- Focus Therapeutic Use
- Acronyms ATORV15
- 07 Sep 2018 Status changed from active, no longer recruiting to completed.
- 20 Aug 2015 New trial record